These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 36269386)

  • 1. Assessing the value of second-trimester nasal bone hypoplasia in predicting chromosomal abnormalities: a retrospective chromosomal microarray analysis of 351 fetuses.
    Pan L; Liang H; Meng Z; Wang J; Zhang R; Wu Y
    Arch Gynecol Obstet; 2023 Oct; 308(4):1263-1270. PubMed ID: 36269386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal Microarray Analysis for the Prenatal Diagnosis in Fetuses with Nasal Bone Hypoplasia: A Retrospective Cohort Study.
    Huang H; Cai M; Ma W; Lin N; Xu L
    Risk Manag Healthc Policy; 2021; 14():1533-1540. PubMed ID: 33889037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second-trimester using chromosomal microarray analysis.
    Chen X; Jiang Y; Zeng S; Zhuang J; Lin N
    Birth Defects Res; 2024 May; 116(5):e2351. PubMed ID: 38766695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual risk of clinically significant copy number variations in fetuses with nasal bone absence or hypoplasia after excluding non-invasive prenatal screening-detectable findings.
    Xia Z; Zhou R; Xu Y; Li Y; Tan J; Luo C; Meng L; Huang M; Qiao F; Hu P; Mao P; Wu Y; Xu Z; Wang Y
    Clin Chim Acta; 2024 Jan; 553():117744. PubMed ID: 38158003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism array (SNP-array) analysis for fetuses with abnormal nasal bone.
    Xie X; Su L; Li Y; Shen Q; Wang M; Wu X
    Arch Gynecol Obstet; 2024 Jun; 309(6):2475-2482. PubMed ID: 37430178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of chromosomal analysis for 29 cases of fetuses with nasal bone absence or hypoplasia].
    Hou L; Wang XX; Jiang HL; Zhang T; Li L; Zhang WY; Wang X
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(43):3532-3535. PubMed ID: 30481905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 10. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
    Du L; Xie HN; Zheng J; He M
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoplastic nasal bone: A potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray.
    Gu YZ; Nisbet DL; Reidy KL; Palma-Dias R
    Prenat Diagn; 2019 Jan; 39(2):116-123. PubMed ID: 30578730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of ultrasound markers in screening fetal trisomy 21].
    Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of chromosomal microarray in fetuses with increased nuchal translucency.
    Zhao XR; Gao L; Wu Y; Wang YL
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of chromosomal microarray analysis in prenatal diagnosis of fetuses with increased nuchal translucency].
    Ni M; Li J; Zhu X; Zhu Y; Gu L; Wu X; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Oct; 36(10):970-974. PubMed ID: 31598938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of copy number variation sequencing in fetuses with increased nuchal translucency: a retrospective study.
    Yang X; Bian X; Shi X; Ding J; Tang H; Xu P; Deng D; Zeng W; Chen S; Qiao F; Feng L; Wu Y
    Arch Gynecol Obstet; 2024 Jan; 309(1):139-144. PubMed ID: 36602560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal chromosomal microarray analysis in 2466 fetuses with ultrasonographic soft markers: a prospective cohort study.
    Hu T; Tian T; Zhang Z; Wang J; Hu R; Xiao L; Zhu H; Lai Y; Wang H; Liu S
    Am J Obstet Gynecol; 2021 May; 224(5):516.e1-516.e16. PubMed ID: 33122027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absent fetal nasal bone in the second trimester and risk of abnormal karyotype in a prescreened population of Chinese women.
    Du Y; Ren Y; Yan Y; Cao L
    Acta Obstet Gynecol Scand; 2018 Feb; 97(2):180-186. PubMed ID: 29164604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
    Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
    Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal and perinatal outcomes of twin pregnancy discordant for one fetus with nuchal translucency above the 95th percentile.
    Shi X; Liu Q; He W; Liu Y; Rao T; Fang L; Wu J
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3152-3157. PubMed ID: 32907415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
    Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.